BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Atossa Therapeutics\, Inc. (ATOS) investor events
X-WR-CALNAME:Atossa Therapeutics\, Inc. (ATOS) investor events
DESCRIPTION:Earnings calls and investor events for Atossa Therapeutics\, In
 c. (ATOS)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Atossa Therapeutics\, I
 nc. (ATOS)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:4bcf94c3-fee4-425e-a4da-b409257fecc9@equibles.com
DTSTAMP:20260617T191003Z
DTSTART;VALUE=DATE:20260109
DTEND;VALUE=DATE:20260110
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Atossa Therapeutics\, Inc. (ATOS) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:3cd7cdbe-a728-4bbc-b9ea-848cd7a84450@equibles.com
DTSTAMP:20261002T212546Z
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260520
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Atossa Therapeutics\, Inc. (ATOS) Investor Update: Endoxifen's Role
  in Breast Cancer | Virtual KOL Event
DESCRIPTION:Endoxifen's Role in Breast Cancer | Virtual KOL Event\nThe star
 t time has not been announced.\nWebcast: https://investors.atossatherapeut
 ics.com/events-presentations?item=23
URL:https://equibles.com/stocks/atos/events/3cd7cdbe-a728-4bbc-b9ea-848cd7a
 84450
END:VEVENT
END:VCALENDAR
